“…As IL-6 participates in various cellular and physiological responses during the inflammatory reaction [21], IL-6 inhibitors can be used in treatment of psychiatric disorders, Alzheimer's disease, diabetes, cancer, depression SAR and QSAR in Environmental Research 885 and rheumatoid arthritis [22][23][24]. Small compounds that are identified as IL-6 inhibitors (Figure 2) include nitrogen-containing benzophenones [25], β-chloro-vinyl chalcones [26,27], 4-styryl-coumarin derivatives [28], derivatives of N-aryl urea [29], methoxylated chalcones [30], thalidomide analogues [31], pyrazolo [3,4-b]pyridines [32], 3,5-diaryl pyridines and meta-terphenyls [33], 2,2-bisaminomethylated aurone analogues [34], pyrazole chalcones [35] and pyridine-5(6H)-one analogues [36]. Tocilizumab, an anti-interleukin-6 receptor antibody, has been approved for the treatment of rheumatoid arthritis, Castleman's disease and juvenile idiopathic arthritis [37].…”